# AntiCoagulation Tracking InterVention and Evaluation

> **NCT04059965** · NA · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Anticoagulation
- Atrial Fibrillation
- Atrial Flutter
- Pulmonary Embolus/Emboli
- Deep Vein Thrombosis
- Stroke
- Hypercoagulability

## Interventions

- **OTHER:** Panel Management for Anticoagulation Therapy
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT04059965
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2022-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04059965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04059965, "AntiCoagulation Tracking InterVention and Evaluation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04059965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*